Works matching DE "ESOMEPRAZOLE"

Results: 590

Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 6, p. 1739, doi. 10.1111/bcp.16402

By:

Wilkes, Sarah;
van de Wiel, Kayleigh;
Mulder, Kelly;
van Ballegooijen, Hanne;
Zaal, Rianne;
van der Kuy, Hugo

Publication type:

Article

The calcium-sensing receptor in bone metabolism: from bench to bedside and back.

Published in:

Osteoporosis International, 2015, v. 26, n. 8, p. 2055, doi. 10.1007/s00198-015-3203-1

By:

Cianferotti, L.;
Gomes, A.;
Fabbri, S.;
Tanini, A.;
Brandi, M.

Publication type:

Article

Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 1, p. 71, doi. 10.1007/s00228-022-03423-x

By:

Issa, Issa;
Skov, Jakob;
Falhammar, Henrik;
Calissendorff, Jan;
Lindh, Jonatan D.;
Mannheimer, Buster

Publication type:

Article

Evaluation of drug-drug interactions of pemigatinib in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1887, doi. 10.1007/s00228-021-03184-z

By:

Ji, Tao;
Rockich, Kevin;
Epstein, Noam;
Overholt, Heather;
Wang, Phillip;
Chen, Xuejun;
Punwani, Naresh;
Yeleswaram, Swamy

Publication type:

Article

Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 11, p. 1639, doi. 10.1007/s00228-021-03167-0

By:

Tsujimoto, Hiroyuki;
Hirata, Yuki;
Ueda, Yasuhiro;
Kinoshita, Naohiko;
Tawa, Hideki;
Tanaka, Yasuyoshi;
Koshiba, Ryoji;
Ota, Kazuhiro;
Kojima, Yuichi;
Kakimoto, Kazuki;
Takeuchi, Toshihisa;
Miyazaki, Takako;
Nakamura, Shiro;
Higuchi, Kazuhide

Publication type:

Article

Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 227, doi. 10.1007/s00228-018-2564-8

By:

Farhat, Nawal;
Haddad, Nisrine;
Birkett, Nicholas;
Momoli, Franco;
Wen, Shi-Wu;
Mattison, Donald R;
Krewski, Daniel;
Crispo, James;
McNair, Doug

Publication type:

Article

The race for drug approvals: hasten slowly?

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1197, doi. 10.1007/s00228-018-2490-9

By:

Braillon, Alain

Publication type:

Article

Randomised trial of the effect of a gastrin/CCK receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 2, p. 129, doi. 10.1007/s00228-016-2150-x

By:

Boyce, Malcolm;
Berg, Frans;
Mitchell, Toni;
Darwin, Kate;
Warrington, Steve

Publication type:

Article

Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 12, p. 1461, doi. 10.1007/s00228-015-1912-1

By:

Becker, M.;
Franken, W.;
Karapinar, F.;
Verzijl-Zeegers, R.;
Schalekamp, T.;
van der Hoeven, R.

Publication type:

Article

The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 7, p. 859, doi. 10.1007/s00228-014-1681-2

By:

Larsen, Michael;
Schou, Mette;
Kristiansen, Anja;
Hallas, Jesper

Publication type:

Article

Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs).

Published in:

2009

By:

Klotz, Ulrich

Publication type:

Editorial

Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 9, p. 685, doi. 10.1007/s00228-006-0148-5

By:

Warrington, Steve;
Baisley, Kathy;
Dunn, Kate;
Boyce, Malcolm;
Morocutti, Anna

Publication type:

Article

Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 9, p. 667, doi. 10.1007/s00228-004-0797-1

By:

Dybdahl, Torben;
Andersen, Morten;
Søndergaard, Jens;
Kragstrup, Jakob;
Kristiansen, Ivar

Publication type:

Article

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 8, p. 531, doi. 10.1007/s00228-004-0804-6

By:

Röhss, Kerstin;
Lind, Tore;
Wilder-Smith, Clive

Publication type:

Article

The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.

Published in:

European Journal of Clinical Pharmacology, 2002, v. 58, n. 7, p. 453, doi. 10.1007/s00228-002-0502-1

By:

Junghard, Ola;
Hassan-Alin, Mohammed;
Hasselgren, Göran

Publication type:

Article

Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.

Published in:

Digestive Diseases, 2018, v. 36, n. 4, p. 257, doi. 10.1159/000489557

By:

Boltin, Doron;
Zvidi, Ibrahim;
Raskin, Maria;
Kayless, Hen;
Schmilovitz-Weiss , Hemda ;
Gingold-Belfer, Rachel;
Niv, Yaron;
Dickman, Ram

Publication type:

Article

Effectiveness and Safety of Pylera® in Patients Infected by <bold>Helicobacter Pylori</bold>: A Multicenter, Retrospective, Real Life Study.

Published in:

Digestive Diseases, 2018, v. 36, n. 4, p. 264, doi. 10.1159/000487391

By:

Tursi, Antonio;
Franceschi, Marilisa;
Allegretta, Leonardo;
Savarino, Edoardo;
De Bastiani, Rudi;
Elisei, Walter;
Baldassarre, Gianluca;
Ferronato, Antonio;
Scida, Serena;
Miraglia, Chiara;
Penna, Antonio;
Licci, Claudio;
Rizzo, Giovanni Luca;
Pranzo, Giuseppe;
Cassieri, Claudio;
Brandimarte, Giovanni;
Picchio, Marcello;
Di Mario, Francesco

Publication type:

Article

Rifaximin-Based Regimens for Eradication of Helicobacter pylori: A Pilot Study.

Published in:

Digestive Diseases, 2006, v. 24, n. 1/2, p. 195, doi. 10.1159/000090330

By:

Gasbarrini, Antonio;
Lauritano, Ernesto Cristiano;
Nista, Enrico Celestino;
Candelli, Marcello;
Gabrielli, Maurizio;
Santoro, Michele;
Zocco, Maria Assunta;
Cazzato, Alessia;
Finizio, Rosalba;
Ojetti, Veronica;
Cammarota, Giovanni;
Gasbarrini, Giovanni

Publication type:

Article

Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy.

Published in:

Digestive Diseases, 2004, v. 22, n. 2, p. 221, doi. 10.1159/000080323

By:

R. Kiesslich;
S. Kanzler;
M. Vieth;
M. Moehler;
J. Neidig;
B.J. Thanka Nadar;
D. Schilling;
J. Burg;
B. Nafe;
M.F. Neurath;
P.R. Galle

Publication type:

Article

Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors.

Published in:

JAMA Network Open, 2024, v. 7, n. 7, p. e2419851, doi. 10.1001/jamanetworkopen.2024.19851

By:

Carollo, Massimo;
Crisafulli, Salvatore;
Selleri, Margherita;
Piccoli, Luca;
L'Abbate, Luca;
Trifirò, Gianluca

Publication type:

Article

Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study

Published in:

Helicobacter, 2024, v. 29, n. 5, p. 1, doi. 10.1111/hel.13143

By:

Lee, Jung Won;
Kim, Nayoung;
Lee, Jongchan;
Jo, So Young;
Lee, Dong Ho

Publication type:

Article

Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial.

Published in:

Helicobacter, 2024, v. 29, n. 5, p. 1, doi. 10.1111/hel.13133

By:

Cheung, Ka Shing;
Lyu, Tao;
Deng, Zijie;
Han, Shaowei;
Ni, Li;
Wu, Juan;
Tan, Jing Tong;
Qin, Jian;
Ng, Ho Yu;
Leung, Wai K.;
Seto, Wai‐Kay

Publication type:

Article

Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial.

Published in:

Helicobacter, 2024, v. 29, n. 4, p. 1, doi. 10.1111/hel.13121

By:

Ding, Yu‐Ming;
Zhang, Qiu‐Mei;
Li, Rui‐Li;
Han, Zhong‐Xue;
Zhao, Qing;
Xu, Li‐Dong;
Wang, Ke‐Yu;
Nan, Xue‐Ping;
Duan, Miao;
Zeng, Shu‐Yan;
Kong, Qing‐Zhou;
Wang, Hui;
Wu, Xiao‐Qi;
Zhang, Ning;
Li, Yan‐Qing;
Zuo, Xiu‐Li;
Li, Yue‐Yue

Publication type:

Article

14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority controlled trial.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13076

By:

Amiot, Aurelien;
Hacoon, Jérémy;
Heluwaert, Frederic;
Mion, François;
Lamarque, Dominique;
Moussata, Driffa;
Mimouni, Maroua;
Delchier, Jean‐Charles;
Durand‐Zaleski, Isabelle;
Audureau, Etienne;
Bastuji‐Garin, Sylvie;
Kedzia, Cecile;
Samia, Baloul;
Dalila, Selmane;
Amel, Gouja;
Petitdidier, Nicolas;
Gagniere, Charlotte;
Martin, Antoine;
Levy, Michael;
Nebbad, Biba

Publication type:

Article

A "new" option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting.

Published in:

Helicobacter, 2023, v. 28, n. 3, p. 1, doi. 10.1111/hel.12962

By:

Macedo Silva, Vítor;
Lima Capela, Tiago;
Freitas, Marta;
Boal Carvalho, Pedro;
Magalhães, Joana;
Cotter, José

Publication type:

Article

Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori.

Published in:

Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12948

By:

Wang, Yujiao;
Dai, Xiaosong;
Gao, Caiping;
Yang, Xue

Publication type:

Article

Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial.

Published in:

Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12935

By:

Tian, Xue‐li;
Suo, Bao‐jun;
Zhang, Hua;
Lu, Hao‐ping;
Li, Cai‐ling;
Zhang, Yu‐xin;
Ren, Xin‐lu;
Yao, Xing‐yu;
Zhou, Li‐ya;
Song, Zhi‐qiang

Publication type:

Article

Pylera® plus ranitidine vs Pylera® plus esomeprazole in first‐line treatment of Helicobacter pylori infection: Two pilot studies.

Published in:

Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12606

By:

Ciccaglione, Antonio Francesco;
Cellini, Luigina;
Marzio, Leonardo

Publication type:

Article

Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.

Published in:

Helicobacter, 2018, v. 23, n. 5, p. 1, doi. 10.1111/hel.12496

By:

Xie, Yong;
Zhang, Zhenyu;
Hong, Junbo;
Liu, Wenzhong;
Lu, Hong;
Du, Yiqi;
Wang, Weihong;
Xu, Jianming;
Wang, Xuehong;
Huo, Lijuan;
Zhang, Guiying;
Lan, Chunhui;
Li, Xiaoyan;
Li, Yanqing;
Wang, Hong;
Zhang, Guoxin;
Zhu, Yin;
Shu, Xu;
Chen, Ye;
Wang, Jiangbin

Publication type:

Article

Brief report: <italic>Lactobacillus bulgaricus </italic>GLB44 (Proviotic<sup>™</sup>) plus esomeprazole for <italic>Helicobacter pylori</italic> eradication: A pilot study.

Published in:

Helicobacter, 2018, v. 23, n. 2, p. 1, doi. 10.1111/hel.12476

By:

Opekun, Antone R.;
Gonzales, Savannah A.;
Al‐Saadi, Mahmoud A.;
Graham, David Y.

Publication type:

Article

Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.

Published in:

Helicobacter, 2017, v. 22, n. 6, p. n/a, doi. 10.1111/hel.12448

By:

Fiorini, Giulia;
Saracino, Ilaria Maria;
Zullo, Angelo;
Gatta, Luigi;
Pavoni, Matteo;
Vaira, Dino

Publication type:

Article

Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area.

Published in:

Helicobacter, 2013, v. 18, n. 6, p. 459, doi. 10.1111/hel.12062

By:

Georgopoulos, Sotirios D.;
Xirouchakis, Elias;
Martinez‐Gonzalez, Beatriz;
Sgouras, Dionyssios N.;
Spiliadi, Charikleia;
Mentis, Andreas F.;
Laoudi, Fotini

Publication type:

Article

Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment for Helicobacter pylori Eradication in China.

Published in:

Helicobacter, 2012, v. 17, n. 6, p. 478, doi. 10.1111/j.1523-5378.2012.00993.x

By:

Qian, Juan;
Ye, Feng;
Zhang, Jun;
Yang, Yan-Mei;
Tu, Hui-Ming;
Jiang, Qi;
Shang, Li;
Pan, Xiao-Lin;
Shi, Rui-Hua;
Zhang, Guo-Xin

Publication type:

Article

Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori.

Published in:

Helicobacter, 2012, v. 17, n. 3, p. 216, doi. 10.1111/j.1523-5378.2012.00937.x

By:

Chuah, Seng-Kee;
Hsu, Ping-I;
Chang, Kuo-Chin;
Chiu, Yi-Chun;
Wu, Keng-Liang;
Chou, Yeh-Pin;
Hu, Ming-Luen;
Tai, Wei-Chen;
Chiu, King-Wah;
Chiou, Shue-Shian;
Wu, Deng-Chyang;
Hu, Tsung-Hui

Publication type:

Article

One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin.

Published in:

Helicobacter, 2008, v. 13, n. 1, p. 69, doi. 10.1111/j.1523-5378.2007.00588.x

By:

Miehlke, Stephan;
Schneider-Brachert, Wulf;
Kirsch, Christian;
Morgner, Andrea;
Madisch, Ahmed;
Kuhlisch, Eberhard;
Haferland, Christian;
Bästlein, Elke;
Jebens, Claus;
Zekorn, Christian;
Knoth, Holger;
Stolte, Manfred;
Lehn, Norbert

Publication type:

Article

Second-Line Treatment for Helicobacter pylori Infection: 10-day Moxifloxacin-Based Triple Therapy versus 2-week Quadruple Therapy.

Published in:

Helicobacter, 2007, v. 12, n. 6, p. 623, doi. 10.1111/j.1523-5378.2007.00548.x

By:

Jung Mook Kang;
Nayoung Kim;
Dong Ho Lee;
Young Soo Park;
Yu Rim Kim;
Joo Sung Kim;
Hyun Chae Jung;
In Sung Song

Publication type:

Article

Rabeprazole- versus Esomeprazole-Based Eradication Regimens for H. pylori Infection.

Published in:

Helicobacter, 2007, v. 12, n. 6, p. 633, doi. 10.1111/j.1523-5378.2007.00553.x

By:

I-Chen Wu;
Deng-Chyang Wu;
Hsu, Ping-I.;
Chien-Yu Lu;
Fang-Jung Yu;
Tsang-En Wang;
Wen-Hsiung Chang;
Jyh-Jon Chen;
Fu-Chen Kuo;
Jeng-Yih Wu;
Wen-Ming Wang;
Ming-Jong Bair

Publication type:

Article

Double-Dose, New-Generation Proton Pump Inhibitors Do Not Improve Helicobacter pylori Eradication Rate.

Published in:

Helicobacter, 2007, v. 12, n. 6, p. 638, doi. 10.1111/j.1523-5378.2007.00556.x

By:

Hyo Sun Choi;
Dong Il Park;
Sang Jun Hwang;
Jung Sik Park;
Hong Joo Kim;
Yong Kyun Cho;
Chong Il Sohn;
Woo Kyu Jeon;
Byung Ik Kim

Publication type:

Article

Role of the Preliminary Susceptibility Testing for Initial and After Failed Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and Esomeprazole.

Published in:

Helicobacter, 2006, v. 11, n. 4, p. 237, doi. 10.1111/j.1523-5378.2006.00407.x

By:

Marzio, Leonardo;
Coraggio, Daniela;
Capodicasa, Simona;
Grossi, Laurino;
Cappello, Giorgio

Publication type:

Article

7-Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High-Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity.

Published in:

Helicobacter, 2006, v. 11, n. 1, p. 39, doi. 10.1111/j.0083-8703.2006.00375.x

By:

Antos, David;
Schneider-Brachert, Wulf;
Bästlein, Elke;
Hänel, Christine;
Haferland, Christian;
Buchner, Michael;
Meier, Eberhard;
Trump, Friedrich;
Stolte, Manfred;
Lehn, Norbert;
Bayerdörffer, Ekkehard

Publication type:

Article

Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.

Published in:

Journal of Gastroenterology, 2011, v. 46, n. 7, p. 906, doi. 10.1007/s00535-011-0402-1

By:

Tan, Victoria;
Wong, Wai;
Cheung, Ting;
Lai, Kam;
Hung, Ivan;
Chan, Pierre;
Pang, Roberta;
Wong, Benjamin

Publication type:

Article

Intravenous Proton Pump Inhibitors.

Published in:

Drugs, 2009, v. 69, n. 4, p. 435, doi. 10.2165/00003495-200969040-00004

By:

Bardou, Marc;
Martin, Janet;
Barkun, Alan

Publication type:

Article

High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study.

Published in:

Annals of Gastroenterology, 2015, v. 28, n. 4, p. 448

By:

Zullo, Angelo;
Ridola, Lorenzo;
De Francesco, Vincenzo;
Gatta, Luigi;
Hassan, Cesare;
Alvaro, Domenico;
Bellesia, Annamaria;
de Nucci, Germana;
Manes, Gianpiero

Publication type:

Article

A Case-Control Study of Esomeprazole Plus Rebamipide vs. Omeprazole Plus Rebamipide on Post-ESD Gastric Ulcers.

Published in:

Japanese Clinical Medicine, 2013, n. 4, p. 7, doi. 10.4137/JCM.S11320

By:

Maki Bunno;
Kyosuke Gouda;
Kunihiro Yamahara;
Masanori Kawaguchi

Publication type:

Article

A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis.

Published in:

Clinical Pharmacology, 2016, v. 8, p. 199, doi. 10.2147/CPAA.S106234

By:

Thomas, Binny;
Mohamed, Mahmoud;
Hail, Moza Al;
Awwad, Fatma Alzahra Y.;
Wahba, Ramy M.;
Hassan, Sabir B.;
Omar, Khalid;
Kassem, Wessam El;
Rouf, Palivalappila Abdul

Publication type:

Article

Gastric Acid-Related Diseases: Focus on Esomeprazole.

Published in:

Clinical Medicine Insights: Therapeutics, 2010, n. 2, p. 439, doi. 10.4137/CMT.S4500

By:

Al-Judaibi, B.;
Chande, N.;
Dresser, G. K.;
Sultan, N.;
J. C. Gregor

Publication type:

Article

Distinct Clusters of Testosterone Levels, Symptoms, and Serum Trace Elements in Young Men: A Cross-Sectional Analysis.

Published in:

Nutrients, 2025, v. 17, n. 5, p. 867, doi. 10.3390/nu17050867

By:

Tanaka, Takazo;
Kojo, Kosuke;
Suetomi, Takahiro;
Nagumo, Yoshiyuki;
Midorikawa, Haruhiko;
Matsuda, Takaaki;
Nakazono, Ayumi;
Shimizu, Takuya;
Fujimoto, Shunsuke;
Ikeda, Atsushi;
Kandori, Shuya;
Negoro, Hiromitsu;
Takayama, Tatsuya;
Nishiyama, Hiroyuki

Publication type:

Article

Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues.

Published in:

Nutrients, 2023, v. 15, n. 15, p. 3458, doi. 10.3390/nu15153458

By:

Baj, Jacek;
Kowalska, Beata;
Barbachowska, Aleksandra;
Forma, Alicja;
Flieger, Michał;
Majerek, Dariusz;
Teresiński, Grzegorz;
Flieger, Wojciech;
Portincasa, Piero;
Buszewicz, Grzegorz;
Radzikowska-Büchner, Elżbieta;
Flieger, Jolanta

Publication type:

Article

Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.

Published in:

Open Access Rheumatology: Research & Reviews, 2013, v. 5, p. 1, doi. 10.2147/OARRR.S41420

By:

Datto, Catherine;
Hellmund, Richard;
Siddiqui, Mohd Kashif

Publication type:

Article

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells.

Published in:

OncoTargets & Therapy, 2023, v. 16, p. 425, doi. 10.2147/OTT.S406009

By:

Duan, Jingya;
Zhang, Zisen;
Du, Jinfeng;
Zhang, Jihua;
Li, Minmin;
Li, Canyu

Publication type:

Article